<DOC>
	<DOCNO>NCT00378560</DOCNO>
	<brief_summary>A study evaluate efficacy , immunogenicity , safety tolerability V501 adult woman</brief_summary>
	<brief_title>V501 Efficacy Study Women Aged 18 26 ( V501-027 )</brief_title>
	<detailed_description />
	<mesh_term>Vaccines</mesh_term>
	<criteria>Female Subject Aged 18 To 26 Years With 14 Lifetime Sexual Partners Male Subject</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>26 Years</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>